Friday, December 5, 2025
Search

Brown & Brown And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

Via News Editorial Team

October 14, 2022

Brown & Brown  And 5 Other Stocks Have High Sales Growth And An Above 3% Return on Equity

(VIANEWS) - Brown & Brown (BRO), Bright Horizons Family Solutions (BFAM), American Tower (AMT) are the highest sales growth and return on equity stocks on this list.

Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?

1. Brown & Brown (BRO)

22.6% sales growth and 14.91% return on equity

Brown & Brown, Inc. sells and markets insurance products in the United States, Bermuda, Canada, Cayman islands, Ireland, and Canada. The company operates in four areas: Retail, National Programs and Wholesale Brokerage. It offers builders risk, pharmaceutical and property group, home-owners, retire benefit, cyber, disability, risk mitigation warranty products, directors, officers, management liability and errors, as well as medical stop loss and excess liability. Personal auto, umbrella and general liability are some of its products. It also provides professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, and real estate title professionals, as well as supplementary insurance-related products for weddings, events, medical facilities, and cyber liability; homeowners and personal property policies, residential earthquake, and private passenger automobile and motorcycle coverage; commercial and public entity-related programs; and flood insurance, commercial difference-in-conditions, all-risk commercial property, coastal property programs, lender-placed solutions, sovereign Indian nations, and parcel insurance. It also markets surplus and excess commercial insurance products such as personal lines for homeowners, jewel, yachts and commercial property, casualty and commercial vehicle, garage, restaurant and builder's risks, and inland maritime lines. Third-party claims administration, medical utilization management and services in workers' compensation, all-lines liability, Medicare Benefits Advocacy, Social Security Disability, Medicare benefits advocacy and claims adjustment services are available. It was established in Daytona Beach in Florida in 1939.

Earnings Per Share

As for profitability, Brown & Brown has a trailing twelve months EPS of $1.85.

PE Ratio

Brown & Brown has a trailing twelve months price to earnings ratio of 32.74. Meaning, the purchaser of the share is investing $32.74 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 14.91%.

Volume

Today's last reported volume for Brown & Brown is 573653 which is 51.56% below its average volume of 1184410.

2. Bright Horizons Family Solutions (BFAM)

16% sales growth and 6.66% return on equity

Bright Horizons Family Solutions Inc. offers child care, early education, support services and educational advice services. It also provides other solutions for families and employers. There are three main segments to the company: Full Service Center Based Child Care, Back Up Care, Educational Advisory and Other Services. Full Service Center Based Child Care offers traditional, center-based child and preschool care, as well as elementary and early education. The Back-Up care segment offers center-based child care as well as in-home care for children and adults/elder dependents, and reimbursed services. Educational Advisory and Other Services offers student loan repayment program management, tuition assistance, and workforce education. It also provides related educational consulting and services. It had 1,014 child and early education centres in America, Puerto Rico and the United Kingdom. Bright Horizons Solutions Corp. was the company's name before it changed to Bright Horizons Family Solutions Inc. on July 2012. Bright Horizons Family Solutions Inc. is located in Newton, Massachusetts. It was established in 1986.

Earnings Per Share

As for profitability, Bright Horizons Family Solutions has a trailing twelve months EPS of $0.45.

PE Ratio

Bright Horizons Family Solutions has a trailing twelve months price to earnings ratio of 127.78. Meaning, the purchaser of the share is investing $127.78 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.66%.

Yearly Top and Bottom Value

Bright Horizons Family Solutions's stock is valued at $56.99 at 20:22 EST, way below its 52-week high of $171.91 and higher than its 52-week low of $56.15.

Revenue Growth

Year-on-year quarterly revenue growth grew by 17.8%, now sitting on 1.82B for the twelve trailing months.

3. American Tower (AMT)

9% sales growth and 31.09% return on equity

American Tower Corporation is one of the most important global REITs. It's a leader in independent ownership, operation, and development of multitenant telecom real estate. The company has a portfolio that includes approximately 219,000 communication sites. For more information about American Tower, please visit the "Earnings Materials" and "Investor Presentations" sections of our investor relations website at www.americantower.com.

Earnings Per Share

As for profitability, American Tower has a trailing twelve months EPS of $4.31.

PE Ratio

American Tower has a trailing twelve months price to earnings ratio of 44.09. Meaning, the purchaser of the share is investing $44.09 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.09%.

Yearly Top and Bottom Value

American Tower's stock is valued at $190.02 at 20:22 EST, way below its 52-week low of $211.38.

Growth Estimates Quarters

The company's growth estimates for the ongoing quarter and the next is a negative 36.7% and a negative 1%, respectively.

Volume

Today's last reported volume for American Tower is 2840120 which is 72.93% above its average volume of 1642330.

Moving Average

American Tower's worth is way under its 50-day moving average of $257.28 and way below its 200-day moving average of $252.63.

4. Vertex Pharmaceuticals (VRTX)

8.9% sales growth and 24.65% return on equity

Vertex Pharmaceuticals Incorporated is a biotechnology firm that develops and markets therapies to treat cystic fibrosis. SYMDEKO/SYMKEVI and ORKAMBI are available to patients suffering from cystic fibrosis. TRIKAFTA is for patients 6 and older with CF who possess at least one F508del mutation. VX-864 is being developed for AAT deficiency treatment and is currently in Phase 2. Clinical trial. VX147 is for treatment of APOL1 mediated focal segmental glomerulosclerosis (or FSGS) and other severe kidney disease. VX-880 is for treatment of Type 1 Diabetes and is in Phase 1/2 clinical trials. VX-548 is a NaV1.8 inhibitor that treats acute, neuropathic and musculoskeletal pain and is in Phase 3. Clinical trial. CTX001 is for treatment of severe SCD/T and TDT and TDT. It sells products to specialty pharmacies, specialty distributors, retail chains and hospitals around the world. Affinia Therapeutics, Inc., Arbor Biotechnologies, Inc., and CRISPR Therapeutics AG are some of its collaborations. ; Kymera Therapeutics, Inc., Mammoth Biosciences, Inc., Moderna, Inc., Obsidian Therapeutics, Inc., Skyhawk Therapeutics, Inc., Ribometrix, Inc., Genomics plc, Merck KGaA, Darmstadt, Germany, as well as X-Chem, Inc. Vertex Pharmacs Incorporated was established in Boston, Massachusetts in 1989.

Earnings Per Share

As for profitability, Vertex Pharmaceuticals has a trailing twelve months EPS of $10.49.

PE Ratio

Vertex Pharmaceuticals has a trailing twelve months price to earnings ratio of 28.31. Meaning, the purchaser of the share is investing $28.31 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 24.65%.

Moving Average

Vertex Pharmaceuticals's value is higher than its 50-day moving average of $288.72 and way above its 200-day moving average of $263.86.

Yearly Top and Bottom Value

Vertex Pharmaceuticals's stock is valued at $296.95 at 20:22 EST, below its 52-week high of $305.95 and way higher than its 52-week low of $177.71.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 2.8% and 0.3%, respectively.

5. AB InBev (BUD)

8.6% sales growth and 6.79% return on equity

Anheuser-Busch InBev SA/NV is involved in the distribution and sale of beer and alcoholic beverages worldwide. The portfolio includes Budweiser and Stella Artois, as well as Beck's and Hoegaarden and Leffe brands. It was established in Leuven in Belgium in 1366.

Earnings Per Share

As for profitability, AB InBev has a trailing twelve months EPS of $0.7.

PE Ratio

AB InBev has a trailing twelve months price to earnings ratio of 66.27. Meaning, the purchaser of the share is investing $66.27 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.79%.

Sales Growth

AB InBev's sales growth is 6.5% for the current quarter and 8.6% for the next.

Revenue Growth

Year-on-year quarterly revenue growth grew by 9.3%, now sitting on 56.5B for the twelve trailing months.

Growth Estimates Quarters

The company's growth estimates for the present quarter and the next is 10.9% and 4%, respectively.

Moving Average

AB InBev's worth is below its 50-day moving average of $50.93 and way under its 200-day moving average of $56.69.

6. The Bank of Princeton (BPRN)

5.6% sales growth and 11.53% return on equity

Bank of Princeton offers a variety of banking services and products. Checking, saving, attorney trust and money market accounts are accepted by the bank. Certificates of deposit can also be issued. The company offers loans for commercial, multi-family, industrial, commercial, residential, first-lien mortgages, home equity and consumer loans. It also offers debit and credit cards, money orders, automatic teller machines and cashier's check, secure deposit boxes and wire transfers. Night depository, bank-by mail, internet banking, telephone banking and payroll-related services are some of its offerings. There are 21 branches located in Princeton. These include parts of Somerset, Hunterdon and Middlesex counties, Ocean, Gloucester and Camden counties, as well as Bucks, Montgomery and Philadelphia counties. Princeton is the home of The Bank of Princeton. It was established in 2007.

Earnings Per Share

As for profitability, The Bank of Princeton has a trailing twelve months EPS of $3.69.

PE Ratio

The Bank of Princeton has a trailing twelve months price to earnings ratio of 7.74. Meaning, the purchaser of the share is investing $7.74 for every dollar of annual earnings.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 11.53%.

Yearly Top and Bottom Value

The Bank of Princeton's stock is valued at $28.57 at 20:22 EST, way below its 52-week high of $32.05 and higher than its 52-week low of $26.57.

Sales Growth

The Bank of Princeton's sales growth is 9.5% for the present quarter and 5.6% for the next.